Lynx1 Capital Management LP, 10% Owner at Korro Bio, Inc. (KRRO), bought 6,684 shares at $11.40 ($79K) on 2026-08-06, disclosed to the SEC on 2026-08-13.
Lynx1 Capital Management LP purchased 5,222 shares of Korro Bio for $59,529.76 at $11.40, marking the largest insider purchase in the company's history and signaling strong conviction in the stock's potential.
KRRO is trading at $13.29, up 9.11% over the last 5 days and 29.53% over the last 90 days, despite being down 29.79% over the past year and sitting 76.22% below its 52-week high of $55.89.
1) Zacks upgraded KRRO to a Buy (Zacks Rank #2) on August 10, 2026. 2) The stock surged 17.6% on June 19, 2026, driven by higher-than-average volume. 3) The insider purchase is the largest ever recorded for the company.
1) The stock is down 29.79% over the past year and is currently trading 76.22% below its 52-week high. 2) KRRO reported a Q4 loss of -175.08% on earnings and -13.87% on revenue on March 12, 2026.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.40 | 5,222 | $60K | 75.5% |
| 2 | $13.19 | 1,462 | $19K | 24.5% |
| Total | $11.79 avg | 6,684 | $79K | 100% |
| Filing → |
| TCRX | BUY | 2025-12-23 | $218K | — | Filing → |
| NEUP | BUY | 2025-10-23 | $6.6M | — | Filing → |
| CGEM | BUY | 2025-10-21 | $2.5M | — | Filing → |